BrightPath Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4594?
Owner Type	Number of Shares	Ownership Percentage
Institutions	1,330,822	1.56%
Individual Insiders	3,410,600	4%
General Public	80,549,878	94.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 31.5%.

Top Shareholders

Top 18 shareholders own 13.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.08%	Rakuten Investment Management, Inc.	1,774,100	JP¥78.1m	133%	0.03%
1.66%	Macquarie Group, Ltd., Banking & Securities Investments	1,418,500	JP¥62.4m	84.6%	no data
1.42%	Evolution Capital Management LLC	1,212,000	JP¥53.3m	-2.79%	0.34%
0.82%	Xiya Tang	700,000	JP¥30.8m	0%	no data
0.77%	Matsui Securities Co. Ltd., Asset Management Arm	661,000	JP¥29.1m	0.02%	0.13%
0.76%	au Kabucom Securities Co., Ltd., Asset Management Arm	651,300	JP¥28.7m	132%	0.16%
0.7%	Hiroshi Akeo	600,000	JP¥26.4m	0%	no data
0.57%	Takehiko Nakazato	490,000	JP¥21.6m	15.3%	no data
0.55%	JPMorgan Chase & Co, Brokerage and Securities Investments	472,256	JP¥20.8m	-182%	no data
0.55%	Kazumi Araki	467,300	JP¥20.6m	0%	no data
0.53%	Mitsubishi UFJ Capital Co., Ltd.	450,000	JP¥19.8m	0%	0.12%
0.48%	SBI Holdings Inc., Asset Management Arm	412,994	JP¥18.2m	0%	no data
0.48%	Japan Securities Finance Co. Ltd., Asset Management Arm	408,600	JP¥18.0m	0%	no data
0.44%	Shunsuke Nakamura	373,000	JP¥16.4m	0%	no data
0.42%	Kazuhiko Kaneko	355,300	JP¥15.6m	0%	no data
0.29%	Nomura Holdings Inc, Securities & Investment Arm	250,100	JP¥11.0m	-78.7%	no data
0.28%	Kenichi Nagai	240,000	JP¥10.6m	0%	no data
0.22%	Akira Yamada	185,000	JP¥8.1m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 07:40
End of Day Share Price	2025/02/12 00:00
Earnings	2018/12/31
Annual Earnings	2018/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BrightPath Biotherapeutics Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.